#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15518	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2269	671.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1430	1430	C	851	C	843	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27926	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3624	759.8	0	.	n	.	0	A20C	SNP	20	20	A	337	337	C	565	C,A	513,41	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27926	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3624	759.8	0	.	n	.	0	T695C	SNP	695	695	T	1012	1012	C	882	C,T	868,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27926	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3624	759.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1955	1955	G	837	G,A,T	811,14,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27926	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3624	759.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2288	2288	C	883	C,T,A	858,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27926	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3624	759.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2362	2362	A	861	A	848	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27926	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3624	759.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2914	2914	C	807	C	791	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1894	folP	855	855	100.0	folP.l15.c4.ctg.1	1664	112.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1047	1049	AGC	196;197;196	A;G;C	190;193;193	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5240	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3331	155.3	1	SNP	p	S91F	1	.	.	271	273	TTC	630	632	TTC	189;186;186	T;T;C	188;183;183	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5240	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3331	155.3	1	SNP	p	D95G	1	.	.	283	285	GGC	642	644	GGC	179;179;173	G;G;C	172;174;169	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5240	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3331	155.3	1	SNP	p	G95N	0	.	.	283	285	GGC	642	644	GGC	179;179;173	G;G;C	172;174;169	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1710	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1414	119.5	1	SNP	p	G45D	0	.	.	133	135	GGC	492	494	GGC	194;190;189	G;G,A;C	192;187,1;186	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	872	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	942	91.3	0	.	n	.	0	G98A	SNP	98	98	G	445	445	A	192	A,G	175,10	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	872	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	942	91.3	0	.	n	.	0	A197.	DEL	197	197	A	543	543	A	202	A	201	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4898	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	164.5	1	SNP	p	D86N	0	.	.	256	258	GAC	609	611	GAC	181;181;182	G;A;C	177;169;180	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4898	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	164.5	1	SNP	p	R87I	0	.	.	259	261	CGT	612	614	CGT	185;186;185	C;G,A;T	181;182,2;176	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4898	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	164.5	1	SNP	p	S87R	1	.	.	259	261	CGT	612	614	CGT	185;186;185	C;G,A;T	181;182,2;176	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4898	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	164.5	1	SNP	p	R87W	0	.	.	259	261	CGT	612	614	CGT	185;186;185	C;G,A;T	181;182,2;176	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4898	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	164.5	1	SNP	p	S88P	0	.	.	262	264	TCC	615	617	TCC	184;186;184	T;C;C	182;183;182	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4062	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2617	153.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1553	1555	GGC	194;189;188	G;G;C	191;183;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1302	1304	GCA	220;221;223	G,A,C;C;A,C	211,1,1;213;217,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1305	1307	ATC	224;223;222	A;T;C,G	216;218;214,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1317	1319	GTG	220;216;216	G,A;T,C;G,C	213,1;204,1;212,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1317	1319	GTG	220;216;216	G,A;T,C;G,C	213,1;204,1;212,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1821	1823	ACC	198;195;194	A,G;C;C,T	193,1;192;191,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1875	1877	GCG	174;175;178	G;C,G;G,C	159;147,1;162,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1875	1877	GCG	174;175;178	G;C,G;G,C	159;147,1;162,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1998	2000	AGC	159;159;160	A,G;G;C,T,A	154,3;153;153,3,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2007	2009	GGC	157;151;148	G,A;G,A;C	151,3;148,1;144	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4024	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2567	152.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2025	2027	CCG	123;127;126	C;C;G	115;118;119	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6044	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3317	179.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1740	1742	CCG	228;227;228	C;C,T;G,A	200;214,1;205,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2338	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1960	116.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	497	497	C	164	C,G	151,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	561	563	GAA	231;232;233	G;A;A	229;230;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	0	.	p	.	0	K41D	NONSYN	121	123	AAA	570	572	GAC	242;239;241	G;A;C,A	239;233;231,5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	0	.	p	.	0	K120N	NONSYN	358	360	AAG	807	809	AAT	225;224;225	A,G;A,G;T,G	220,1;221,1;213,5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	972	974	TCA	221;216;219	T;C;A	216;210;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1101	1103	GTC	215;221;222	G,A;T,G;C	197,5;209,1;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1173	1175	GTT	240;232;233	G;T,C;T,C	233;216,8;219,7	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	1	SNP	p	A121D	1	.	.	361	363	GAC	810	812	GAC	225;221;223	G,A;A,C,T;C	216,5;215,1,1;218	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2962	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1640	178.7	1	SNP	p	D121N	0	.	.	361	363	GAC	810	812	GAC	225;221;223	G,A;A,C,T;C	216,5;215,1,1;218	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	141	93.62	porB3.l15.c4.ctg.2	264	27.5	0	.	p	.	0	E313A	NONSYN	937	939	GAA	88	90	GCA	26;25;25	G;C;A	20;21;20	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	141	93.62	porB3.l15.c4.ctg.2	264	27.5	0	.	p	.	0	N314D	NONSYN	940	942	AAC	91	93	GAC	25;25;23	G;A;C	20;21;22	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	141	93.62	porB3.l15.c4.ctg.2	264	27.5	0	.	p	.	0	F316I	NONSYN	946	948	TTC	97	99	ATC	15;12;12	A;T;C	14;11;11	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	141	93.62	porB3.l15.c4.ctg.2	264	27.5	0	.	p	.	0	A318S	NONSYN	952	954	GCG	103	105	TCG	9;9;10	T;C;G	9;9;10	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	141	93.62	porB3.l15.c4.ctg.2	264	27.5	0	.	p	.	0	G321S	NONSYN	961	963	GGC	112	114	AGC	13;13;13	A;G;C	10;12;13	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	141	93.62	porB3.l15.c4.ctg.2	264	27.5	0	.	p	.	0	G322A	NONSYN	964	966	GGT	115	117	GCC	14;15;15	G;C;C	12;15;14	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	141	93.62	porB3.l15.c4.ctg.2	264	27.5	0	.	p	.	0	G324V	NONSYN	970	972	GGT	121	123	GTT	19;20;22	G;T;T	17;19;19	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	144	96.53	porB3.l15.c4.ctg.4	149	0.0	0	.	p	.	0	S273T	NONSYN	817	819	TCG	24	26	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	144	96.53	porB3.l15.c4.ctg.4	149	0.0	0	.	p	.	0	K278N	NONSYN	832	834	AAA	39	41	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	144	96.53	porB3.l15.c4.ctg.4	149	0.0	0	.	p	.	0	R279H	NONSYN	835	837	CGC	42	44	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	208	92.34	porB3.l15.c4.ctg.5	252	1.9	0	.	p	.	0	L253V	NONSYN	757	759	TTG	81	83	GTA	3;3;3	G,T;T;A,G	2,1;3;2,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	208	92.34	porB3.l15.c4.ctg.5	252	1.9	0	.	p	.	0	V260L	NONSYN	778	780	GTA	102	104	TTA	2;2;2	T,G;T;A	0,2;2;2	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	516	418	porB3	990	208	92.34	porB3.l15.c4.ctg.5	252	1.9	0	.	p	.	0	A277fs	FSHIFT	829	829	G	153	153	G	2	G	2	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10196	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5002	201.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1168	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1133	101.4	1	SNP	p	V57M	1	.	.	169	171	ATG	563	565	ATG	229;230;232	A;T;G	225;225;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
